Page last updated: 2024-08-16

propiverine and silodosin

propiverine has been researched along with silodosin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ashitomi, K; Kadekawa, K; Nishijima, S; Sugaya, K; Yamamoto, H	1
Funahashi, Y; Gotoh, M; Kato, M; Matsukawa, Y; Takai, S; Yamamoto, T	1
Dahm, P; Gandhi, S; Hwang, EC; Imamura, M; Jung, JH; Kim, MH; Pang, R	1

Reviews

1 review(s) available for propiverine and silodosin

Article	Year
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. The Cochrane database of systematic reviews, 2018, 10-11, Volume: 10 Topics: Adrenergic alpha-Antagonists; Benzilates; Drug Combinations; Ethamsylate; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Plant Extracts; Prostatic Hyperplasia; Prostatism; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urological Agents	2018

Article

Year

Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.

The Cochrane database of systematic reviews, 2018, 10-11, Volume: 10

Topics: Adrenergic alpha-Antagonists; Benzilates; Drug Combinations; Ethamsylate; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Plant Extracts; Prostatic Hyperplasia; Prostatism; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urological Agents

2018

Trials

1 trial(s) available for propiverine and silodosin

Article	Year
Long-term efficacy of a combination therapy with an anticholinergic agent and an α1-blocker for patients with benign prostatic enlargement complaining both voiding and overactive bladder symptoms: A randomized, prospective, comparative trial using a urody Neurourology and urodynamics, 2017, Volume: 36, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzilates; Cholinergic Antagonists; Drug Therapy, Combination; Humans; Indoles; Male; Middle Aged; Prostatic Hyperplasia; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Urological Agents	2017

Article

Year

Long-term efficacy of a combination therapy with an anticholinergic agent and an α1-blocker for patients with benign prostatic enlargement complaining both voiding and overactive bladder symptoms: A randomized, prospective, comparative trial using a urody

Neurourology and urodynamics, 2017, Volume: 36, Issue:3

Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzilates; Cholinergic Antagonists; Drug Therapy, Combination; Humans; Indoles; Male; Middle Aged; Prostatic Hyperplasia; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Urological Agents

2017

Other Studies

1 other study(ies) available for propiverine and silodosin

Article	Year
Excitatory effect of propiverine hydrochloride on urethral activity in rats. International journal of urology : official journal of the Japanese Urological Association, 2012, Volume: 19, Issue:6 Topics: Adrenergic alpha-Antagonists; Animals; Benzilates; Female; Imidazoles; Indoles; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Naphthalenes; Piperazines; Prazosin; Pressure; Rats; Rats, Sprague-Dawley; Urethra; Urinary Bladder	2012

Article

Year

Excitatory effect of propiverine hydrochloride on urethral activity in rats.

International journal of urology : official journal of the Japanese Urological Association, 2012, Volume: 19, Issue:6

Topics: Adrenergic alpha-Antagonists; Animals; Benzilates; Female; Imidazoles; Indoles; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Naphthalenes; Piperazines; Prazosin; Pressure; Rats; Rats, Sprague-Dawley; Urethra; Urinary Bladder

2012